Monoclonal Antibody 105AD7 Anti-idiotype Vaccine

Preferred Label : Monoclonal Antibody 105AD7 Anti-idiotype Vaccine;

NCIt definition : A cancer vaccine consisting of a humanized monoclonal antibody that mimics a tumor-associated antigen 791Tgp72 (also known as CD55). Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing CD55, resulting in tumor cell lysis. (NCI04);

Détails

Origin ID

C2648;

UMLS CUI

C1134469;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
is_component_of_chemotherapy_regimen
- Alum Adjuvant/Monoclonal Antibody 105AD7 Anti-Idiotype Vaccine [NCIt concept]
- BCG/Monoclonal Antibody 105AD7 Anti-idiotype Vaccine [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients